Retrospective analysis of anti-inflammatory therapies during the first wave of COVID-19 at a community hospital

doi:10.5492/wjccm.v10.i5.244

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7892)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-8) series.

Item

Count

PDF

307

WORD

143

HTML

4176

Figures (1-2)

214

Tables (1-8)

274

Sum=5114

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

357

Download

892

Sum=1249

Publishing Process of This Article

Item

Count

Browse

463

Download

1066

Sum=1529

Sep 9, 2021 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Critical Care Medicine

ISSN

2220-3141

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Crit Care Med. Sep 9, 2021; 10(5): 244-259
Published online Sep 9, 2021. doi: 10.5492/wjccm.v10.i5.244

Table 5 Unadjusted Cox proportional hazards analysis of independent predictors of survival in intensive care unit patients with coronavirus disease 2019

	B	SE	P value	HR	95%CI
Age	0.031	0.007	< 0.001	1.032	1.02-1.05
Sex (male)	0.39	0.2	0.046	1.48	1.008-2.2
Vasopressors	0.485	0.2	0.016	1.62	1.095-2.4
GC administration (all patients)¹	-0.61	0.19	0.002	0.54	0.37-0.79

¹Treatment stratified as total patients receiving GC therapy (GC alone and GC + tocilizumab).

HR: Hazard ratio; CI: Confidence interval; GC: Glucocorticoids.

Citation: Iglesias JI, Vassallo AV, Sullivan JB, Elbaga Y, Patel VV, Patel N, Ayad L, Benson P, Pittiglio M, Gobran E, Clark A, Khan W, Damalas K, Mohan R, Singh SP. Retrospective analysis of anti-inflammatory therapies during the first wave of COVID-19 at a community hospital. World J Crit Care Med 2021; 10(5): 244-259
URL: https://www.wjgnet.com/2220-3141/full/v10/i5/244.htm
DOI: https://dx.doi.org/10.5492/wjccm.v10.i5.244